What is NDC 69945-050?

69945-050 is the product NDC for Octreoscan (indium in -111 pentetreotide) kit, listed with the FDA by Curium US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Octreoscan (Indium In -111 Pentetreotide).

Curium US LLC, NDC labeler code 69945. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Octreoscan?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Octreoscan NDC 69945-050 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69945-050Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69945-0050Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69945-050-40	6994500504069945005040	1 KIT in 1 BOX (69945-050-40) * 1 mL in 1 VIAL, GLASS * 1 mL in 1 VIAL, GLASSMarketed from Oct 14, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Octreoscan
Generic name (nonproprietary): indium in -111 pentetreotide
Dosage form: Kit
Labeler: Curium US LLCNDC labeler code 69945
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020314
Marketing start: Oct 14, 2015
Listing expires: Dec 31, 2027
Identifiers: Product ID 69945-050_3d7648ab-7b11-495d-925c-3a991065237eSPL ID 3d7648ab-7b11-495d-925c-3a991065237eSPL set ID 93d8f3b2-1216-41dc-a63d-0e812b33891d

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N469945005040 followed by a unit qualifier and the quantity

Package 69945-0050-40. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 21, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Octreoscan, after radiolabeling, is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69945-050

What is NDC 69945-050?: 69945-050 is the product NDC for Octreoscan (indium in -111 pentetreotide) kit, listed with the FDA by Curium US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Octreoscan (Indium In -111 Pentetreotide).
Who is the labeler?: Curium US LLC, NDC labeler code 69945. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Octreoscan?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Octreoscan (Indium in -111 pentetreotide) NDC 69945-050